Scholar Rock Holding buy tbackenh
Start price
19.03.26
/
40%
€39.20
Target price
19.03.27
€50.00
Performance (%)
-1.02%
Price
20.03.26
€38.80
Summary
This prediction is currently active. With a performance of -1.02%, the BUY prediction for Scholar Rock Holding by tbackenh is down slightly. This prediction currently runs until 19.03.27. The prediction end date can be changed by tbackenh at any time. tbackenh has 40% into this predictionScholar Rock is a clinical-stage biopharmaceutical company that engages in the discovery and development of innovative medicines to treat serious diseases in patients that currently have limited or no treatment options. Their pipeline consists of a number of product candidates that target growth factor signaling pathways within the human body. These products hold potential for the treatment of multiple diseases, including neuromuscular disorders, cancer, and fibrosis. Scholar Rock, which trades under the symbol SRRK, is listed on the NASDAQ stock exchange.
Performance without dividends (%)
| Name | 1w |
|---|---|
| Scholar Rock Holding | -1.02% |
| iShares Core DAX® | -2.117% |
| iShares Nasdaq 100 | -1.323% |
| iShares Nikkei 225® | -0.324% |
| iShares S&P 500 | -1.568% |
According to tbackenh what are the pros and cons of Scholar Rock Holding for the foreseeable future?
Pros
Innovative
Some uniques
Cons
overvalued
Higher risks for its business